학술논문

289 PGV-001: a phase 1 trial of a personalized neoantigen peptide vaccine for the treatment of malignancies in the adjuvant setting
Document Type
article
Source
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Subject
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Language
English
ISSN
2051-1426